Skip to main content
SBT ULTRASONIC TECHNOLOGY CO.,LTD. logo

SBT ULTRASONIC TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 688392 ISIN · CNE100005P15 Shanghai Stock Exchange Manufacturing
Filings indexed 483 across all filing types
Latest filing 2025-12-19 Legal Proceedings Report
Country CN China
Listing Shanghai Stock Exchange 688392

About SBT ULTRASONIC TECHNOLOGY CO.,LTD.

https://www.sbt-sh.com/en/

SBT Ultrasonic Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced ultrasonic equipment and solutions. The company focuses on high-precision ultrasonic metal welding, plastic welding, and wire bonding technologies. Its product portfolio includes ultrasonic welding systems for lithium-ion batteries, wire bonders for semiconductor packaging, and ultrasonic cutting and cleaning equipment. Serving sectors such as new energy vehicles, power electronics, and consumer electronics, the company provides critical assembly solutions for battery tab welding and power module packaging. SBT Ultrasonic emphasizes technological innovation in acoustic systems and digital ultrasonic generators to ensure process stability and efficiency in high-volume manufacturing environments.

Recent filings

Filing Released Lang Actions
关于公司提起诉讼的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement from Shanghai Jiaocheng Ultrasound Technology Co., Ltd. regarding a significant litigation case where the company is the plaintiff. It details the lawsuit's background, parties involved, claims, and potential financial impact. The document does not contain full financial statements or detailed financial performance data but focuses on legal proceedings and their implications. It is a legal proceeding update rather than a full audit report or annual report. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 2007 characters, which is typical for an announcement rather than a full report.
2025-12-19 Chinese
2025年第三季度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled as the "2025 Third Quarter Report" of Shanghai Jiaocheng Ultrasonic Technology Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial metrics for the third quarter period ending September 30, 2025. The report is unaudited as indicated. The length of the document (12,462 characters) and the presence of comprehensive financial statements and analysis confirm it is a substantive financial report for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report (10-K). Therefore, the correct classification is IR with high confidence. 9M 2025
2025-10-28 Chinese
关于2025年前三季度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's profit distribution plan for the first three quarters of 2025. It details the dividend per share, total dividend amount, and the basis for distribution. It references the 2025 third quarter report but does not contain the full financial statements or detailed financial analysis itself. The document is a formal announcement of the dividend distribution plan, including board resolutions and shareholder meeting authorizations. It is not a full financial report, earnings release, or annual/interim report. The content fits the category of Notice of Dividend Amount (DIV), as it announces dividend amounts, payment details, and related shareholder information.
2025-10-28 Chinese
关于2025年第三季度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Jiaocheng Ultrasound Technology Co., Ltd. regarding the provision for asset impairment for the third quarter of 2025. It details the amounts of credit impairment losses and asset impairment losses recognized for the quarter ending September 30, 2025. The document includes explanations of the impairment testing and the impact on the company's financial results for the quarter. It is a formal announcement of a specific accounting action (asset impairment provision) approved by the board and audit committee, but it does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report. The document length is 1726 characters, which is relatively short and focused on a specific accounting provision rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about an accounting provision rather than a full quarterly report or earnings release.
2025-10-28 Chinese
关于参加2025年上海辖区上市公司三季报集体业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement from Shanghai Jiaocheng Ultrasound Technology Co., Ltd. about their participation in a collective performance explanation meeting for the 2025 third quarter report. It details the meeting time, location, format, participants, and how investors can engage. The document does not contain the actual financial report or detailed financial data but rather informs about the upcoming investor presentation related to the quarterly results. Given the document length (1491 characters) and content, it is an announcement of an investor presentation event rather than the presentation itself or the quarterly report. Therefore, the appropriate classification is Investor Presentation (IP).
2025-10-28 Chinese
首次公开发行部分限售股上市流通公告
Regulatory Filings Classification · 95% confidence The document is an official announcement regarding the listing and circulation of restricted shares following the company's initial public offering (IPO). It details the number of shares becoming freely tradable, the lock-up periods, shareholder commitments not to reduce holdings, and related regulatory approvals. It references specific dates for share circulation and includes commitments from major shareholders and management. The document is not a full financial report, audit, or earnings release, but rather a regulatory announcement about share circulation and shareholder commitments post-IPO. It fits the category of a Regulatory Filing (RNS) as it is a formal disclosure related to share listing and shareholder commitments without substantive financial statements or analysis.
2025-09-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.